The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choice

被引：6
|
作者：
Zouein, Joseph [1 ]
Haddad, Fady G. [1 ]
Eid, Roland [1 ]
Kourie, Hampig R. [1 ]
机构：
[1] St Joseph Univ Beirut, Hematol Oncol Dept, Fac Med, Damas St,POB 17-5208, Beirut 11042020, Lebanon
来源：
IMMUNOTHERAPY | 2022年 / 14卷 / 02期
关键词：
chemotherapy; combination therapy; hyperprogressive disease; immune checkpoint inhibitors; immunotherapy; microenvironment; NSCLC; tumor inflammation; PLUS CHEMOTHERAPY; HYPERPROGRESSIVE DISEASE; 1ST-LINE TREATMENT; PHASE-III; NIVOLUMAB; IMMUNOTHERAPY; ATEZOLIZUMAB; CARBOPLATIN; IPILIMUMAB; DOCETAXEL;
D O I：
10.2217/imt-2021-0014
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Lung cancer is the second most common cancer worldwide and the leading cause of death among cancers. The progressive approvals of immunotherapy as first-line treatment options have helped improve cancer prognosis. However, longer follow-up has confirmed the possibility of acquired resistance to immune checkpoint inhibitors (ICIs) which can lead to late relapses. Chemotherapy can act as a priming therapy to increase a tumor's response to immunotherapy. We aim through this review to explain the mechanism behind ICI resistance and the value of chemotherapy in escaping this resistance. Finally, all US FDA approvals regarding the management of metastatic non-small-cell lung cancer using a combination of ICIs and chemotherapy are summarized.
引用
收藏
页码：155 / 167
页数：13
相关论文
共 50 条
  • [1] Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?
    Mok, Tony S. K.
    Loong, Herbert H.
    [J]. LANCET, 2016, 387 (10027): : 1488 - 1490
  • [2] Combing Immune Checkpoint Inhibitors with Radiotherapy in Advanced Non-small-cell Lung Cancer
    Zou, Y.
    Chen, Y.
    Zhou, X.
    Gong, Y.
    Xu, Y.
    Zou, B.
    Peng, F.
    Huang, M.
    Lu, Y.
    Liu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S625 - S625
  • [3] Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non-small cell lung cancer
    Kuo, Chih-Hsi Scott
    Wang, Chin-Chou
    Huang, Yu-Chen
    Pavlidis, Stelios
    Liu, Chien-Ying
    Ko, How-Wen
    Chung, Fu-Tsai
    Lin, Tin-Yu
    Wang, Chih-Liang
    Guo, Yi-Ke
    Yang, Cheng-Ta
    [J]. THORACIC CANCER, 2019, 10 (05) : 1158 - 1166
  • [4] Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer
    Fuschillo, Salvatore
    Battiloro, Ciro
    Rocco, Danilo
    D Gravara, Luigi
    Motta, Andrea
    Maniscalco, Mauro
    [J]. BIOMARKERS IN MEDICINE, 2020, 14 (11) : 929 - 932
  • [5] Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer
    Morita, Ayako
    Ichihara, Eiki
    Inoue, Koji
    Fujiwara, Keiichi
    Yokoyama, Toshihide
    Harada, Daijiro
    Ando, Chihiro
    Kano, Hirohisa
    Oda, Naohiro
    Tamura, Tomoki
    Ochi, Nobuaki
    Kawai, Haruyuki
    Inoue, Masaaki
    Hara, Naofumi
    Fujimoto, Nobukazu
    Ichikawa, Hirohisa
    Oze, Isao
    Hotta, Katsuyuki
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (09) : 1607 - 1615
  • [6] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
    Kitadai, Rui
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 777 - 785
  • [7] Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis
    Xu, Zexi
    Feng, Jia
    Weng, Yiming
    Jin, Yao
    Peng, Min
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [8] Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review
    Ellis, Peter M.
    Vella, Emily T.
    Ung, Yee C.
    [J]. CLINICAL LUNG CANCER, 2017, 18 (05) : 444 - U75
  • [9] The efficacy of immune checkpoint inhibitors in advanced non-small-cell lung cancer with liver metastases
    Rui Kitadai
    Yusuke Okuma
    Taiki Hakozaki
    Yukio Hosomi
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 777 - 785
  • [10] Immune Checkpoint Inhibitors for Brain Metastases of Non-Small-Cell Lung Cancer
    Ashinuma, H.
    Shingyoji, M.
    Iuchi, T.
    Yoshida, Y.
    Setoguchi, T.
    Hasegawa, Y.
    Sakaida, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
12345